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Abstract
Cardiovascular diseases (CVD) are leading causes of premature mortality in India. Evidence from developed
countries shows that mortality from these can be substantially prevented using population-wide and individual-
based strategies. Policy initiatives for control of CVD in India have been suggested but evidence of efficacy has
emerged only recently. These initiatives can have immediate impact in reducing morbidity and mortality. Of the
prevention strategies, primordial involve improvement in socioeconomic status and literacy, adequate healthcare
financing and public health insurance, effective national CVD control programme, smoking control policies,
legislative control of saturated fats, trans fats, salt and alcohol, and development of facilities for increasing physical
activity through better urban planning and school-based and worksite interventions. Primary prevention entails
change in medical educational curriculum and improved healthcare delivery for control of CVD risk factors-
smoking, hypertension, dyslipidemia and diabetes. Secondary prevention involves creation of facilities and human
resources for optimum acute CVD care and secondary prevention. There is need to integrate various policy makers,
develop effective policies and modify healthcare systems for effective delivery of CVD preventive care.
Introduction
It is now established that non-communicable diseases
especially cardiovascular diseases (CVD) are major causes
of death and disability in low income countries including
India [1]. In India the latest Registrar General of India
report confirms that circulatory diseases [CVD, coronary
heart disease (CHD) and stroke] are the largest cause of
deaths. This is observed in all regions of the country, in
men and women (Table 1) [2]. Prevalence of CVD and its
risk factors is rapidly increasing [3] and it causes major
burden on healthcare systems [4]. Although policy initia-
tives for prevention and control of CVD and other chronic
diseases in India have been proposed earlier [4], some evi-
dence for their efficacy is now emerging within the coun-
try. This is in addition to international evidence of efficacy
of these measures [5]. This essay summarises current data
on epidemiology of CVD in India and suggests evidence-
based policy interventions for their prevention and control.
Cardiovascular diseases in India
World Health Organization (WHO) reports that non-
communicable chronic diseases (NCDs) are responsible
for about 70% of all worldwide deaths [5]. In India mor-
tality data from Registrar General of India prior to 1998
were obtained from predominantly rural populations
where vital registration varied from 5-15% [6]. The Mil-
lion Death Study collected mortality statistics from all
the Indian states using country-wide Sample Registra-
tion System units [2]. Causes of deaths in more than
113,000 subjects from 1.1 million homes were analysed
using a validated verbal autopsy instrument as reported
earlier [7]. CVD were the largest causes of deaths in
males (20.3%) as well as females (16.9%) and led to 1.7-
2.0 million deaths annually. Regional studies have also
reported that CVD is the leading cause of deaths in
urban [8] as well as rural [9] populations. WHO has
predicted that from years 2000 to 2020 DALYs lost
from CHD in India shall double in both men and
women from the current 7.7 and 5.5 million respectively
[3]. Prevalence studies report that CHD diagnosed using
history and ECG changes have trebled in both urban
and rural adults from early 1960s and current preva-
lence rates are 10-12% in urban and 4-5% in rural adults
[3]. Stroke is also increasing in India [3] and incidence
registries using population-based surveillance have
reported that annual incidence of stroke varies from
100-150/100,000 population in urban locations with
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any medium, provided the original work is properly cited.greater incidence in rural regions [10-13]. These studies
provide only limited information and there is need for
properly designed prospective studies to correctly iden-
tify trends.
The increase in CHD and stroke in India is largely an
urban phenomenon and only recently a rapid rise in
rural populations has been reported [3]. There are no
prospective studies that have identified risk factors of
importance. The case-control INTERHEART study
reported that standard risk factors such as smoking,
abnormal lipids, hypertension, diabetes, high waist-hip
ratio, sedentary lifestyle, psychosocial stress, and lack of
consumption of fruits and vegetables explained more
than 90% of acute CHD events in South Asians [14].
Similar conclusions were reached using urban-rural
comparisons in risk factors and smaller case-control stu-
dies [3]. The INTERSTROKE study reported that ten
common risk factors explained more than 90% incident
haemorrhagic and thrombotic strokes [15]. The risk fac-
tors are similar to the INTERHEART study but the
population attributable risks are different with greater
importance of hypertension and lesser importance of
diabetes and lipids. Reviews of epidemiological studies
suggest that all the major risk factors are increasing in
India [16-20]. Tobacco production and consumption has
increased [16]. Smoking is increasing among young sub-
jects (20-35 years) according to second and third
National Family Health Surveys [17]. Prevalence of
hypertension has increased in both urban and rural sub-
jects and presently is 25-40% in urban and 10-15%
among rural adults [18]. Lipids levels are increasing and
serial studies from a north Indian city reported increas-
ing mean levels of total, LDL and non-HDL cholesterol
and triglycerides and decreasing HDL cholesterol [19].
Although there are large regional variations in preva-
lence of diabetes it has more than quadrupled in the last
20 years from <1-3% to 10-15% in urban and 3-5% in
rural areas [20]. Studies have reported increasing obesity
as well as truncal obesity, due to sedentary lifestyles and
psychosocial stress in the country [21,22].
Prevention of cardiovascular diseases
Control of risk factors has led to 50-80% decline in inci-
dence of CVD in high income countries [5,23]. On the
other hand, in absence of proper preventive approaches
the risk factors are increasing in low and middle income
countries [1]. WHO has classified prevention as popula-
tion-based primordial, individual-based primary and
patient-based secondary prevention [5]. Of the two
approaches to prevention, the population approach is
used to address the behavioural risk factors at the com-
munity level and its success depends on surveillance,
population-wide education, partnerships with commu-
nity organizations, assurance of health services, environ-
mental change and policy and legislative initiatives. This
approach addresses a selected list of modifiable risk fac-
tors such as diet, smoking and tobacco use, sedentary
lifestyle, and availability of screening and diagnostic ser-
vices. The high risk individual-based prevention
approach should assess risk factors to determine indivi-
dual risk. Medical interventions are often required. Sec-
ondary prevention strategies, on the other hand,
comprise mainly medical interventions in addition to
therapeutic lifestyle changes. A multi-factorial compre-
hensive approach that focuses on policy-based approach
for prevention of cardiovascular disease in all parts of
Table 1 Top ten causes of deaths in India classified according to areas of residence and gender
Rank India (all age
groups)
Economically
backward states
Economically
advanced states
Rural
populations
Urban
populations
Men Women Middle-age
(25-69 years)
1 Cardiovascular Cardiovascular Cardiovascular Cardiovascular Cardiovascular Cardiovascular Cardiovascular Cardiovascular
2 COPD, asthma Diarrhoeas COPD, asthma COPD,
asthma
Cancers COPD,
asthma
Diarrhoeas COPD, asthma
3 Diarrhoea Respiratory
infections
Cancers Diarrhoeas COPD,
asthma
Tuberculosis COPD,
asthma
Tuberculosis
4 Perinatal COPD, asthma Senility Perinatal Tuberculosis Diarrhoeas Respiratory
infections
Cancers
5 Respiratory
infections
Perinatal Diarrhoeas Respiratory
infections
Senility Perinatal Senility Ill-defined
6 Tuberculosis Tuberculosis Tuberculosis Tuberculosis Diarrhoeas Cancers Perinatal Digestive
diseases
7 Cancers Other infections Injuries Cancers Injuries Respiratory
infections
Cancers Diarrhoeas
8 Senility Ill defined Perinatal Senility Ill-defined Injuries Ill defined Injuries
9 Injuries Injuries Ill defined Injuries Digestive Ill defined Tuberculosis Suicides
10 Ill defined Malaria Respiratory
infections
Ill defined Respiratory
infections
Senility Injuries Malaria
Adapted from Registrar General of India report (2009)
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tries, is suggested.
Policy changes are effective
A large body of scientific evidence supports the concept
that policy changes at the government level are the
quickest way to improve population health including
chronic diseases [4,23]. North Karelia, Finland was the
first population level observatory where government-led
policy changes (dietary fat control, smoking policies)
coupled with population-based educational intervention
reduced CVD mortality by 60-80% over the next twenty
years [24]. Similar observations have been reported by
countries in Europe, North America and Japan where
the dietary and smoking policies were put into practice
leading to reduced smoking and cholesterol levels [23].
A slightly different policy was adopted in the US where
aggressive population-level risk factor control and phar-
macotherapy by physicians led to better control of
hypertension and hypercholesterolemia and reduction of
CVD [23].
T h ed e c l i n ei nC V Dm o r t a l i t yi nh i g hi n c o m eE u r -
opean and North American countries has followed two
phases [25]. The first phase in 1970-90s and was due to
population based measures for risk factor control
initiated by changes in policies on smoking, substitution
of vegetable oils for animal fats and physical activity
promotion. The second phase of decline from 1990’st o
date is ascribed to better management of risk factors
and acute CVD syndromes and short-term as well as
long term use of evidence based pharmacotherapies.
Public healthcare financinga n ds t r e n g t h e n i n go fp r i -
mary, secondary and tertiary care is important [26].
Influence of policy changes on CVD mortality in differ-
ent countries is summarised in Table 2 [25-31]. It is
observed that in countries where population based
tobacco control policies, salt and fat control strategies
and focussed control of multiple CVD risk factors
(mainly hypertension and hypercholesterolemia) by phy-
sicians have been actively pursued there has been a sig-
nificant decline in CVD incidence varying from 50-90%
over a 20-30 year period. In middle income countries of
Eastern Europe where such initiatives were delayed
there has been a lesser decline (20-40%). On the other
hand, in low income countries such as China and India
no significant policy initiatives exist and in China there
is evidence of increase in CVD mortality [31]. In India,
reliable mortality data do not exist but there is evidence
of increase in CVD prevalence over the same period [3].
Thus, the decline is mortality from CVD in high
income countries is due mainly to population wide
decrease in risk factors, better risk factor management
and control, and disease management strategies. Primor-
dial prevention is focused as decreasing risk factor load
in the population using strategies for increasing aware-
ness and access through education regarding smoking
and tobacco cessation, dietary modulation (low fat and
high fruit and vegetables intake) and increased physical
activity [26]. It also involves addressing the social deter-
minants of health through improvement in daily living
conditions, fair distribution of power, money and
resources and continuous upgradation of knowledge,
monitoring and skills [32]. Primary prevention is direc-
ted towards control of CVD risk factors such as smok-
ing, hypertension, high low density lipoprotein (LDL)
cholesterol, low high density lipoprotein (HDL) choles-
terol, metabolic syndrome and diabetes so that onset of
manifest CVD is avoided or delayed [26]. Secondary pre-
vention is use of lifestyle changes, risk factor control
and pharmacological strategies in patients with estab-
lished CVD (CHD, stroke and others) and tertiary pre-
vention is use of advanced techniques such as coronary
interventions and bypass surgery in addition to second-
ary prevention strategies in patients with established dis-
ease [26]. Role of policy makers is important at the
levels of all prevention.
Lessons for India
The major challenge for the governments in low income
countries such as India is to develop cost-effective stra-
tegies to respond to threat from CVD with aim to delay
and eliminate premature onset and reduce mortality and
morbidity [4,33]. Prevention and control from all types
of CVD including CHD is a three pronged process and
all these approaches are complimentary (Figure 1).
Social determinants of health are very important for pri-
mordial, primary and secondary prevention and policies
at the government level influence all.
Primordial Prevention
These strategies are focussed on the population wide
reduction of multiple cardiovascular risk factors. Rose
developed the concept of CVD risk as a continuum in a
population and showed that all pathophysiological fac-
tors were continuously distributed in a population [34].
He opined that high-risk and sick individuals simply
represented the extreme end of the statistical distribu-
tion. From this hypothesis evolved the concept of popu-
lation-wide control of risk factors. This would shift the
mean levels of risk factors (e.g., cholesterol, systolic BP)
in the standard normal curve to the left and decrease
number of high-risk individuals. The principal concepts
of the Rose hypotheses are continuity of risk and its
population impact, more disease in subjects at small risk
as compared to less numbers in people with high risk,
prediction of cases using population mean of risk fac-
tors, difference in causes of CVD among population and
individuals, societal characteristics that influence risk,
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Page 3 of 12Table 2 Policy changes in Europe, North America and other countries that led to decline in CVD mortality
Country Political agenda Risk factor prevention Better risk factor and disease management Decline in CVD
mortality
Strengthening of
healthcare systems for
acute and chronic CVD
care
Public
healthcare
financing and
insurance
Tobacco
control
policies
Food-
modification
initiatives
Physical
activity
promotion
Chronic diseases/
CVD focused
physician
education
Aggressive population
based pharmacological
risk factor control
CVD
focused
primary
care
CVD focused
secondary/
tertiary care
Period
evaluated
Percent
change
Western
Europe
23
++++ ++++ +++ ++ ++ ++++ ++ +++ +++ 1970-2000 (-) 40-
45%
Finland
22 ++++ ++++ +++ ++ +++ ++++ ++ +++ +++ 1972-2007 (-) 75-
80%
Germany
25 ++++ ++++ +++ ++ +++ ++++ ++ +++ +++ 1980-2000 (-) 39-
50%
Spain
22 ++++ ++++ +++ +++ +++ ++++ ++ +++ +++ 1970-2000 (-) 48-
50%
England
26 ++++ ++++ +++ ++ ++ ++++ +++ ++++ +++ 1984-2004 (-) 48-
52%
Australia
27 ++++ ++++ +++ ++ ++ ++++ +++ ++++ +++ 1968-2000 (-) 83%
USA
28 +++ ++ ++ ++ ++ ++++ ++++ +++ ++++ 1970-2000 (-) 60%
Russia
23 ++ +++ ++ + + ++ + ++ ++ +++ 1970-2000 (-) 10%
Eastern
Europe
23
++ ++ ++ ++ ++ +++ ++ ++ ++ 1985-2000 (-) 16%
China
29 + +++ + ++ ++ ++ + + ++ 1985-2004 (+) 27-
50%
India
3 + + ++ 0 0 + 0 0 +++ No data –
Scale of 0 to 4+.
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2and implications on policy, research and population
action [34]. The policy and clinical actions for popula-
tion actions for prevention are summarised below.
Improving socioeconomic environment and literacy
The social issues involved in occurrence of premature
CVD and other non-communicable diseases are multiple
and include the social gradient, stress, early life events,
social exclusion, improper working conditions, lack of
social support, addictions including tobacco/alcohol,
food scarcity or excess and uneven distribution, lack of
proper transport and illiteracy and low educational sta-
tus [32]. There are macrolevel (governance failure, geo-
politics, natural resources decline, economic policies,
population growth, demographic trap, etc.) and microle-
vel (cultural barriers, poverty trap, lack of innovation
and savings, absence of trade/business, technological
reversal, adverse productivity shock, gender bias, adoles-
cence-related, etc.) factors [30]. Multiple national pro-
grams exist in India to improve socioeconomic status of
the population ranging from literacy improvement
(National Literacy Mission and Right to Education Act)
to employment generation (National Rural Employment
Guarantee Act) and social security (Women’s Health
Plan). These policies are directed to the specific social
issue or population group but not in context of disease
prevention or control. Improving literacy reduces
unhealthy behaviours (e.g., smoking) and increases
awareness of risk factors [35]. It also promotes adher-
ence to lifestyle and pharmacotherapies for primary and
secondary prevention [36]. Both general literacy [37]
a n dh e a l t hl i t e r a c y[ 3 8 ]s h o u l db ep a r to ft h eN a t i o n a l
Literacy Mission. Inter-ministerial collaboration is essen-
tial for policy implementation on CVD prevention and
control (Figure 2) and the Indian National Commission
of Macroeconomics and Health which encompasses
ministries of health, finance, technical education, human
development, youth affairs, sports, women and child
development, agriculture, food and civil supplies, indus-
try, commerce and transport is an important step for-
ward [39].
National CVD health programmes
The existing Indian national health programs are direc-
ted towards communicable diseases and maternal and
child health [40]. Although national program for control
of cardiovascular diseases and diabetes has been
initiated as a pilot it has not been scaled due to paucity
of funds [41]. We believe that it is a priority and the
program and must be spread widely and scope and
funding substantially increased. National Rural Health
Mission of government of India [42] should focus on
improvement of healthcare systems for non-communic-
able diseases and chronic care [43,44]. The National
Urban Health Mission [45] which has been in a plan-
n i n gs t a g ef o ral o n gt i m ea l s on e e d st ob eu r g e n t l y
implemented. Clearly a political will to initiate and sus-
tain these programs is needed. Acute cardiovascular
events (acute myocardial infarction or stroke) should be
deemed notifiable similar to certain infections [40].
Healthcare financing and universal insurance
An important area for CVD control is healthcare finan-
cing by the government. In India the total healthcare
spending is about 5% of the gross national product
(GNP) but government spends less than 1% of GNP [4].
Treating CHD is expensive [46] but unfortunately all
the focus of the government is on development of ter-
tiary care facilities. It is possible to reduce the mortality
and burden of CHD by population wide policies [4].
Financing is needed not only for implementation of pro-
grams for tobacco, alcohol and dietary fat control but
also to improve urban design and provide better educa-
tion within the existing national programmes. Health
insurance for acute and chronic diseases is virtually
non-existent in India [47]. More than 80% population
pays out of pocket for health related expenses and every
year almost 30 million individuals are pushed into pov-
erty for catastrophic healthcare expenditure [48]. India
has the most privatised healthcare system in the world
(<20% public funding) compared to the US (the most
privatised system) where the government health expen-
diture is about 50% of the total [49]. In GNP terms too,
at 0.9 per cent of the governmental health care spending
Evidence Based Acute and Chronic
CVD Management
Clinic based risk factors control.
Smoking cessation, BP control
Lipid and Diabetes management
Improving medical education
Healthcare Financing
Policies for smoking, diet and physical 
activity modulation
Tackling Social Determinants of Health
Figure 1 Cardiovascular prevention pyramid.T h eg r e a t e s t
benefit and CVD reduction is achieved by primordial prevention
measures which involve tackling the social determinants, public
health financing, population policies for smoking cessation,
promotion of healthy diet and physical activity, and changes in
medical education curriculum focussed on preventive care. Clinic
based primary prevention strategies which involve control of blood
pressure, lipids and diabetes are important. Care of acute CVD event
and long-term CVD management with secondary and tertiary
prevention therapies also contribute to reduction to CVD mortality.
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Page 5 of 12in India is one of the lowest in the world [49]. A few
state governments have joined hands with private
insurers to provide health-insurance to general popula-
tion but the impact of such schemes has not been evalu-
ated [50].
Changing medical education curriculum
Primordial and primary prevention of chronic non-com-
municable diseases especially CVD and CHD are not
major component of medical school curricula in India
[40]. At policy level, Medical Council of India should
implement this change. Continuing medical education
for general physicians, general practitioners and others
about advances in cardiovascular and other forms of
therapy should be mandatory [51]. Physicians should be
encouraged to use global risk-assessment tools such as
the Framingham Risk Score [52]. They have to be aware
of various CVD guidelines [53]. Although there is evi-
dence in India that devoted clinicians manage their
patients according to the guidelines [54], the uptake of
preventive efforts is limited [46]. Establishment of sys-
tems to address the multi-level contexts that influence
the development and maintenance of prevention-related
health behaviours is important [33,55]. Hospitals and
health care systems should be encouraged to develop
and provide preventive cardiology services and systems
for the community [51]. And finally there should be
creation and certification for preventive CHD specialists
who can train the practitioners and paramedics in stra-
tegies of prevention and health promotion. Training of
healthcare workers and allied health professionals for
systematic or opportunistic screening is important
[26,51,53]. This would lead to early diagnosis of risk fac-
tors and their management. There is also a need for
Finance, 
Commerce, 
Insurance, Industry
Rural/Urban 
development
Transport
Public Works
Water & Sanitation
Agriculture
Food & Civil Supplies
Education
Technical education
Human Resources
Ministry of 
Health
Planning
Social Determinants of 
Health
Health financing
Health insurance
Tobacco control
Medical Education
Inexpensive drug 
development
Device regulation
Improving literacy
Health literacy
School based 
programs
Healthy food choices
Legislative control of
SFA, TFA, etc
Salt and alcohol 
control
Rural and urban 
planning
Physical activity 
promotion
Work-commute-leisure
Social Development
Women & Child
Poverty Alleviation
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Healthcare 
Units
Secondary Care
District Level
Primary Care
Risk factor control
Risk management
Acute CVD management 
Secondary prevention
Effective Preventive 
Healthcare Delivery
Medical Education
Drugs & Chemicals
Ministry of Health
Actionable Items   Ministries/Departments        Health Administration      Health Care Delivery
Integration of governmental and non-
governmental organizations
Figure 2 Integration of various stake-holders for formulation of policies and implementation of cardiovascular disease prevention and
control in India. Ministry of planning should act as nodal point for action and coordinate and integrate activities of various ministries involved
in planning, policy development and program implementation. Planning ministry along with ministry of health and its various departments
should implement the national cardiovascular disease control program jointly with the state departments of health. There is a need to integrate
various maternal and child health programs and communicable diseases programs with non-communicable diseases programs. Also required is
a multi-level integration (horizontal and vertical) of various governmental and non-governmental organizations involved in healthcare delivery at
the national and state level. SFA saturated fatty acids; TFA trans fatty acids; CVD cardiovascular disease.
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Page 6 of 12creation of cadre of non-communicable disease health
care workers for not only screening but also for ensur-
ing monitoring of individuals and ensuring compliance.
These workers should also be trained to educate the
populace in early diagnosis of acute CVD events and
ensuring referral.
Tobacco control
An important policy action for CVD prevention and
control is enforcement of strict anti-tobacco laws[6]. It
is now well recognised that smoking in any form (cigar-
ettes, bidis and others) as well as use of non-smoked
tobacco is equally dangerous to health, especially CVD
health [56]. Smoking and tobacco use is rampant among
the rural subjects and in low socioeconomic status
urban subjects [35]. The comprehensive legislation on
tobacco control and adoption of the WHO Framework
Convention on Tobacco Control (FCTC) by government
in India is an important step in this direction [57]. Stu-
dies from Europe and North America have reported that
strict enforcement of FCTC have resulted in reduced
admissions due to CHD and decreased mortality [58].
Indian laws need to be amended to comply with the
provisions of the FCTC [59]. There is a considerable
gap in policy and its application. According to a survey
the enforcement of FCTC in India is less than 20% [60].
The government needs to approve anti-smoking laws
and educate the public through organized programs
with media support and enforce the tobacco control leg-
islation strictly.
Healthy diet, salt and alcohol control
Diet is a very controversial area and the current evi-
dence based practices adopted by the western countries
should be carefully evaluated and cautiously implemen-
ted [32,33]. WHO has concluded that as a society
moves up the socioeconomic scale there are substantial
changes that occur in diet [61]. These include greater
consumption of calories, fats, saturated fats, trans-fats,
salt, refined carbohydrates and sugars and decreased
intake of high-fibre foods, legumes and vegetables. A
healthy diet should be the opposite. Guidelines pro-
moted by WHO [61] and Indian national committees
[33,62] suggest: (i) increased intake of fruits and vegeta-
bles (at least 500 g per day), legumes and whole grain
foods; (ii) reduction of the intake of fried foods, pro-
cessed foods, soft drinks containing calories, and other
unhealthy foods; (iii) limitation on the daily intake of
total fat to 25-35% of calories, and saturated fat <7% of
the calories, by limiting the use of butter, ghee, full-fat
dairy products, trans-fats, and tropical oils (palm oil and
coconut oil) and increased intake of mono-unsaturated
fats up to 20%; (iv) reduction of the dietary glycemic
load by cutting down on the carbohydrates, especially
refined carbohydrates; (v) reduction of the intake of salt
to <2.5 gm sodium or <6 gm of salt (one teaspoon of
salt) per day; and (vi) moderation in the use of nuts,
lean meat and fish and alcohol. Government policies are
important to translate knowledge into practice [63]. For
years the food and nutrition policies of the Indian gov-
ernment have focused on problem of undernutrition
[39]. The dual epidemic of under- and over-nutrition
needs a different response. Focus should be on a
balanced healthy diet that tackles problems of both
rather than on overweight/obesity alone. India is, also,
unique because more than 90% of consumed food is
home-made. Following steps can have major immediate
effects: (i) promotion of healthy nutrition in the general
population by implementation of various government of
India guidelines on chronic diseases, diabetes and obe-
sity; (ii) creation of culturally sensitive health educa-
tional material; (iii) subsidies for producing and
distributing healthy foods and fruits; (iv) penal taxation
on unhealthy saturated and hydrogenated fats and subsi-
dies on vegetable oils; (v) food labelling including por-
tion size, calories, total fat, saturated fat, trans-fat,
protein, carbohydrates, sodium, sugar and fibre; (vi)
healthy foods availability at schools and work sites; and
(vii) reduction of salt content in the processed food.
Salt is important in genesis and perpetuation of hyper-
tension and has a direct correlation with CVD [64].
Indian diet has a very high salt content, typically 10-12
g of salt intake per day as recommended by government
agencies [65]. A lower intake is (5-6 g salt/day) sug-
gested by international guidelines [26]. Recommenda-
tions regarding alcohol intake for CVD prevention are
confusing [66]. The overall harm of alcohol due to high
blood pressure, liver disease and accidents and injuries
and is much more than protective effects on CVD [67]
and as policy alcohol should be discouraged.
Policies for physical activity
Regular physical activity is extremely important for CVD
prevention [68]. The recommended physical activity is
30-to-45 minutes of moderate-intensity activity such as
brisk-walking every day. In India, work-related physical
activity is confined to rural and urban low socioeco-
nomic status subjects [69], while leisure time physical
activity is limited to a motivated few in urban areas
[70]. Evidence from Europe and North America reports
beneficial effect on population based initiatives on
increasing physical activity with a public health perspec-
tive [71]. Occupational physical activity and creating
separate time for employees has been the focus of inter-
national agencies [72]. There are examples of multiple
c o m p r e h e n s i v ew o r k s i t eh ealth promotion programs
that focus on improvement of physical activity [73,74].
In India, an industrial worksite intervention program
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with reduced tobacco use and increased physical activity
[75]. Habit of active participation in physical activity
programs, games and sports begins in early childhood
and track to adulthood, therefore, physical education
should be given greater emphasis in schools and colleges
[76]. Yoga can be part of the physical activity among the
school children as its regular participation not only
improves physical capacity but also improves adherence
to other strategies for improving health [33]. In a study
in India 40000 school children in were provided educa-
tional intervention for a 6 month period which resulted
in improved health literacy and health behaviours at one
year [77]. Policy changes have to be implemented and it
is heartening to note that national and state-level educa-
tional boards have included chronic disease prevention
in the course curriculum.
Urban planning is important for public health and
can improve human well-being, emphasize needs
assessment and service delivery, manage complex
social systems, focus at the population level, and rely
on community-based participatory methods [72,78].
The current development of cities has been haphazard
and most are conglomeration of houses and narrow
lanes with no place to walk safely [79]. For CVD pre-
vention there should be encouragement of construc-
tion and use of foot-paths and bicycle-paths. A
u n i f o r mu r b a nd e v e l o p m e n tp o l i c yi sn e e d e dw h i c h
should not only be guided by aesthetics but also by the
health needs of the population. Traditionally, these
plans include planning for community needs in trans-
portation, housing, commercial/office buildings, natural
resource utilization, environmental protection, and
health-care infrastructure [78].
Primary and secondary prevention
This strategy focuses on control of risk factors [26].
Although a large number of CVD risk are described
interventions focussed on the major risk factors (smok-
ing, high BP, high LDL cholesterol, low HDL cholesterol
and diabetes) have shown to lead to substantial decline
in incidence of CVD [80]. Primary prevention strategy
should focus on improving healthcare delivery and tar-
get-oriented control of risk factors [68].
Healthcare delivery for primary prevention
In India the healthcare delivery mechanisms are very
chaotic [4]. For proper delivery of chronic health care
the medical infrastructure needs to be structured like a
pyramid [45]. In this pyramid the maximum emphasis
has to be at the primary level, i.e. at the level of first
contact that should be easily accessible (both physically
and in terms of affordability) by everyone. Each succes-
sive rung needs to be equipped to perform more
complex tasks for more complex conditions. This has to
be followed up with a referral system along this pyramid
[51]. Such a system minimises waste (viz. in the form of
trivial or self-limiting illnesses being treated at district
or state level hospitals) and enhances accessibility. In
India on paper we have such a system in operation [45]
but in reality this system is woefully inadequate. The
infrastructure below the district level is rudimentary.
This places enormous burden on facilities at state and
district levels. The reason for this is two-fold. First,
while in a pyramid the strength of the base is most
important, we somehow have this erroneous notion that
the excellence of the system depends on the apex, i.e.,
specialty hospitals in metropolitan centres. As a policy,
preventive healthcare and chronic disease surveillance
should be delivered by primary care physicians or
trained community health workers [81]. As a large pro-
portion of population in India receives healthcare from
non-governmental sector [82], at a policy level there
should be an effective integration of government and
non-government agencies involved in delivery of pri-
mary health care [83] (Figure 2).
Risk factor control
Aggressive primary prevention is critical to preventing
CVD in those who are in high-risk category with the
four key objectives: (i) avoidance of all tobacco products
and passive exposure to tobacco, (ii) control of dyslipi-
demia, (ii) control of blood pressure, and (iii) control of
blood glucose and diabetes through intense lifestyle
modification and medications if necessary [1,5,53]. Com-
munity worker based model for chronic disease risk fac-
tor control has been tried in many settings with variable
results [81]. This strategy is useful in management of
infections, pregnancy related outcomes and malnutri-
tion. Trials are underway in India to assess their impor-
tance in chronic diseases. Use of practitioners of
alternative systems of medicine could be important for
chronic diseases risk factor management [83]. India has
a strong tradition of religiosity and all gurus recommend
prudent lifestyle- with focus on smoking cessation,
balanced diet, physical exercise and mental relaxation-
important for CVD control.
Secondary prevention
Acute cardiovascular disease management and appropri-
ate long term medical care is crucial in preventing CVD
related mortality [84]. A substantial reduction in CVD
related mortality in high income countries is due to bet-
ter acute coronary care and long term management
[25]. On the other hand availability of care and its stan-
dard is variable in low income countries [1]. There is
need to develop better quality CVD care systems and
manpower in these countries.
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Page 8 of 12There is a need to develop publicly funded primary
and secondary healthcare systems for acute CVD care
[51]. Acute coronary events should be made a notifiable
condition. In India, management practices in acute cor-
onary syndromes are guidelines driven and optimal [54].
Guidelines recommend that lifestyle changes recom-
mended above, aspirin, beta-blockers, angiotensin con-
verting enzyme (ACE) inhibitors and statins be used in
all patients with CVD [84]. There was low use of sec-
ondary prevention therapies in Europe and North Amer-
ica in late 1990’s but the situation has improved due to
policy focus on better management [85]. In India there
is low use of various evidence based medicines, espe-
cially statins and beta-blockers and a rapid decline in
use as the patients move from tertiary to secondary and
primary care [86]. This is due to multiple barriers to
proper management at healthcare systems, healthcare
providers and patient level. Health systems related bar-
riers are in the realm of government policy and action
and need major efforts.
Implementing policy interventions
Healthcare policy implementation requires partnerships
between multiple stakeholders. This is also true for
CVD prevention and control [4,44]. National health pro-
grams in low income countries are often managed as
vertically integrated systems of care with no horizontal
interaction. For example in India there are more than
two dozen national programmes for control of commu-
nicable and non-communicable diseases and maternal
and child health [40]. There is very little integration at
the grass-roots level that leads to low quality expensive
care. Figure 2 shows the proposed flowchart of horizon-
tal and vertical integration of various stake-holders
involved in CVD prevention. The fundamental impor-
tance of social determinants of health in primordial, pri-
mary and secondary CVD prevention is highlighted.
At the ministerial level it has to be realised that there
are multiple determinants of CVD health and all these
need focus. There is need for integrated approach to
policy making with participation of ministries of health,
finance, commerce, industry, social development, rural
and urban development, transport, agriculture, food and
civil supplies, education, human development, informa-
tion and broadcasting, telecommunications, drugs and
chemicals and some others. Planning ministry should
act as a nodal point for all activities (Figure 2). An apex
committee to integrate activities of various ministries
should be formed. Priority agenda for this committee
should be to formulate guidelines for implementing
agenda to modify the social determinants of health,
effective implementation of national CVD control
programme, change the medical education curriculum
with focus on chronic diseases and improving public
health financing and develop low-cost insurance
schemes. Regular assessments of the progress and exter-
nal audits to evaluate performance should be performed.
There should also be a good coordination between the
central and various state governments. Although there is
need for good secondary care, strengthening of primary
health care systems to take care of chronic diseases with
facilities for risk factor identification, risk factor control
and secondary prevention therapies is essential as sug-
gested by WHO and other organizations [87]. With
proper management of health systems using modern
technologies it should be possible to integrate various
programs, both horizontally and vertically, and provide
better acute and chronic diseases control [88]. All this
requires political will and unless such a desire exists in
the country the march of CVD shall continue leading to
premature mortality especially among the low socioeco-
nomic populations [89].
Conclusions
The epidemic of CVD in India needs an urgent policy
response for its control. It is no longer the disease of
the rich or the well-educated. Strategies that have
been successful in upper-middle income countries are
available and need to be implemented [25]. Most of
the achievements are attributable to social change
involving culture, housing and food [90]. Table 3 and
Figure 2 prioritize the agenda for the government.
Political and bureaucratic will and policies for improv-
ing human development index should be implemen-
ted. Initiation of national cardiovascular diseases
control program is important. The medical curricula
need to be extensively revised to incorporate these
diseases into the mainstream. Financing mechanisms
have to be developed for supporting healthcare infra-
structure at primary and secondary levels and for pub-
lic-funded health insurance. Suitable policies for
tobacco control, dietary fat control and better physical
activity need to be enforced. Both primary prevention
for target oriented control of CVD risk factors and
pharmacotherapy based secondary prevention need to
be implemented. Facilities for management of CVD
risk factors in primary care and acute and chronic dis-
ease management in secondary care are needed.
Implementation of these policies can delay the occur-
rence of acute cardiovascular event by at least 10
years, reduce the mortality burden by 25-30%,
decrease utilization of tertiary care, save money, and
reduce the inexorable march of cardiovascular diseases
in India.
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